1. Dehnes Y, Hemmersbach P (2011) Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera) and epoetin delta (Dynepo) on isoelectric erythropoietin profiles and haematological parameters. Drug Test Anal 3(5):291–299
2. European Medicines Agency (EMEA) (2007) MIRCERA scientific discussion,
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000739/WC500033669.pdf
. Accessed 29 Aug 2017, pp 1–4.
3. World Anti-Doping Agency (2016) The world anti-doping code. International Standard. Prohibited list January 2017. Montreal.
https://www.wada-ama.org/sites/default/files/resources/files/2016-09-29_-_wada_prohibited_list_2017_eng_final.pdf
. Accessed 29 Aug 2017.
4. World Anti-Doping Agency (2014) Technical document TD2014EPO. Harmonization of analysis and reporting of ESAs by electrophoretic techniques. Montreal.
https://www.wada-ama.org/sites/default/files/resources/files/WADA-TD2014EPO-v1-Harmonization-of-Analysis-and-Reporting-of-ESAs-by-Electrophoretic-Techniques-EN.pdf
. Accessed 29 Aug 2017.
5. Reichel C, Abzieher F, Geisendorfer T (2009) SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. Drug Test Anal 1(11–12):494–504